Excessive O-GlcNAcylation of proteins suppresses spontaneous cardiogenesis in ES cells

FEBS Letters

Volumn 583, Issue 15, 2009, Pages 2474-2478

  Kim, Hoe Suk ^a,b   Park, Sang Yoon ^c   Choi, Yu Rim ^a   Kang, Jeong Gu ^c   Joo, Hyun Jung ^b   Moon, Woo Kyung ^b   Cho, Jin Won ^c  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Cardiogenesis; Diabetes; Embryonic stem cell; Nkx2.5 transcription factor; O GlcNAcylation; O linked N acetylglucosamine

Indexed keywords

6 DIAZO 5 OXONORLEUCINE; ACETYLGLUCOSAMINIDASE; GLUCOSAMINE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; GREEN FLUORESCENT PROTEIN; N ACETYLGLUCOSAMINE; TRANSFERASE;

ACYLATION; ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; GENE EXPRESSION; HEART MUSCLE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ACETYLGLUCOSAMINE; ACETYLGLUCOSAMINIDASE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; FEMALE; GENE KNOCK-IN TECHNIQUES; HEART; HUMANS; INFANT; MICE; MYOCARDIUM; OXIMES; PHENYLCARBAMATES; STREPTOZOCIN;

EID: 67849106344     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.06.052     Document Type: Article

References (25)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
2. Seppanen M.P., Ojanpera O.S., Kaapa P.O., and Kero P.O. Delayed postnatal adaptation of pulmonary hemodynamics in infants of diabetic mothers. J. Pediatr. 131 (1997) 545-548
3. Clark R.J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., and Dillmann W.H. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 278 (2003) 44230-44237
4. Hu Y., Belke D., Suarez J., Swanson E., Clark R., Hoshijima M., and Dillmann W.H. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ. Res. 96 (2005) 1006-1013
5. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., Anversa P., and Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50 (2001) 2363-2375
6. Love, D.C. and Hanover, J.A. (2005) The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005, re13.
7. Hart G.W., Housley M.P., and Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446 (2007) 1017-1022
8. Liu K., Paterson A.J., Chin E., and Kudlow J.E. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc. Natl. Acad. Sci. USA 97 (2000) 2820-2825
9. Akimoto Y., Kawakami H., Yamamoto K., Munetomo E., Hida T., and Hirano H. Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3802-3809
10. Federici M., et al. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106 (2002) 466-472
11. Cieniewski-Bernard C., Bastide B., Lefebvre T., Lemoine J., Mounier Y., and Michalski J.C. Identification of O-linked N-acetylglucosamine proteins in rat skeletal muscle using two-dimensional gel electrophoresis and mass spectrometry. Mol. Cell Proteomics 3 (2004) 577-585
12. Cieniewski-Bernard C., Mounier Y., Michalski J.C., and Bastide B. O-GlcNAc level variations are associated with the development of skeletal muscle atrophy. J. Appl. Physiol. 100 (2006) 1499-1505
13. Fulop N., Marchase R.B., and Chatham J.C. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc. Res. 73 (2007) 288-297
14. Hescheler J., and Fleischmann B.K. Indispensable tools: embryonic stem cells yield insights into the human heart. J. Clin. Invest. 108 (2001) 363-364
15. Hidaka K., et al. Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J. 17 (2003) 740-742
16. Komuro I., and Izumo S. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc. Natl. Acad. Sci. USA 90 (1993) 8145-8149
17. Kim H.S., Cho J.W., Hidaka K., and Morisaki T. Activation of MEK-ERK by heregulin-beta1 promotes the development of cardiomyocytes derived from ES cells. Biochem. Biophys. Res. Commun. 361 (2007) 732-738
18. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., Naito M., and Nakao K. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408 (2000) 92-96
19. Baba S., et al. Flk1(+) cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model. Cardiovasc. Res. 76 (2007) 119-131
20. Nishikawa S.I., Nishikawa S., Hirashima M., Matsuyoshi N., and Kodama H. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125 (1998) 1747-1757
21. Fujiwara Y., Browne C.P., Cunniff K., Goff S.C., and Orkin S.H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 93 (1996) 12355-12358
22. Haltiwanger R.S., Grove K., and Philipsberg G.A. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. J. Biol. Chem. 273 (1998) 3611-3617
23. McNulty P.H. Hexosamine biosynthetic pathway flux and cardiomyopathy in type 2 diabetes mellitus. Focus on "Impact of type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart". Am. J. Physiol. Cell Physiol. 292 (2007) C1243-C1244
24. Fulop N., Mason M.M., Dutta K., Wang P., Davidoff A.J., Marchase R.B., and Chatham J.C. Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am. J. Physiol. Cell Physiol. 292 (2007) C1370-C1378
25. Abu-Sulaiman R.M., and Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr. Cardiol. 25 (2004) 137-140